TrialHuman vaccines & immunotherapeutics2021

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.

Shangying Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.